TableĀ 1

Population of age-related macular degeneration (AMD) randomised controlled trials (RCTs)

AMD populationNumber of RCTs (%)
Early AMD14 (7.9)
Early AMD, Intermediate6 (3.4)
Early AMD, Intermediate, GA6 (3.4)
Early AMD, Intermediate, GA, nAMD1 (0.6)
GA23 (13)
Intermediate6 (3.4)
Intermediate, GA1 (0.6)
nAMD114 (64.4)
Other6 (3.4)
Total177 (100)
  • Early AMD, several small drusen or a few medium drusen in one/both eyes; GA, geographic atrophy; intermediate AMD, many medium drusen or at least one large drusen in one/both eyes; nAMD, neovascular age-related macular degeneration.